Oral Presentation（Lung） 6 English Session 1

[LOP6-4] Neoadjuvant ALK-TKI therapy for ALK-positive non-small cell lung cancer：updated outcomes from a single-center study and a meta-analysis of relevant publications

Siying Ren¹ (1.Department of Respiratory and Critical Care Medicine, the Second Xiangya Hospital of Central South University, 2.Department of Thoracic Surgery, the Second Xiangya Hospital of Central South University)

Password required to view